| Symbol | ELOX |
|---|---|
| Name | ELOXX PHARMACEUTICALS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 02476 United States MA P.O. Box 274 |
| Telephone | (781) 577-5300 |
| Fax | — |
| — | |
| Website | http://www.eloxxpharma.com/ |
| Incorporation | US |
| Incorporated On | 1999 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Ernst & Young LLP; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001035354 |
| Description | The primary business of the Company is to utilize our patented and patent-pending technology related to antibody genes, antibody discovery technology, modified cow antibodies, and antibody drug candidates, and related technologies for human therapeutic applications to develop novel approaches to treat cancer and inflammatory diseases. Additional info from OTC: |
New Form NT 10-Q - Eloxx Pharmaceuticals, Inc. Filed: 2025-08-14 AccNo: 0001104659-25-078543 Size: 32 KB
Read more(99% Neutral) Eloxx Pharmaceuticals, Inc. (ELOX) Announces Executive Departure
Read moreNew Form NT 10-Q - Eloxx Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049378 Size: 35 KB
Read moreNew Form NT 10-K - Eloxx Pharmaceuticals, Inc. Filed: 2025-04-01 AccNo: 0001104659-25-030543 Size: 32 KB
Read moreNew Form SEC STAFF ACTION - Eloxx Pharmaceuticals, Inc. Filed: 2025-02-21 AccNo: 9999999997-25-000521 Size: 4 KB
Read moreDirector Aggarwal Sumit 🟡 adjusted position in 0 shares (1 derivative) of Eloxx Pharmaceuticals, Inc. (ELOX) Transaction Date: Jan 24, 2025 | Filing ID: 006784
Read moreDirector Rubin Steven D 🟡 adjusted position in 0 shares (1 derivative) of Eloxx Pharmaceuticals, Inc. (ELOX) Transaction Date: Jan 24, 2025 | Filing ID: 006783
Read moreDirector Androski Lindsay 🟡 adjusted position in 0 shares (1 derivative) of Eloxx Pharmaceuticals, Inc. (ELOX) Transaction Date: Jan 24, 2025 | Filing ID: 006782
Read moreDirector Walts Alan Edmund 🟡 adjusted position in 0 shares (1 derivative) of Eloxx Pharmaceuticals, Inc. (ELOX) Transaction Date: Jan 24, 2025 | Filing ID: 006781
Read moreNew Form NT 10-Q - Eloxx Pharmaceuticals, Inc. Filed: 2024-11-19 AccNo: 0001104659-24-120555 Size: 37 KB
Read more